221 related articles for article (PubMed ID: 23236829)
21. [Effects of nuclear factor kappaB and transforming growth factor beta1 in the anti-liver fibrosis process using Ginkgo biloba extract].
Liu SQ; Yu JP; He L; Yu HG; Luo HS
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):903-7. PubMed ID: 16381635
[TBL] [Abstract][Full Text] [Related]
22. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis.
Mizumoto M; Arii S; Furutani M; Nakamura T; Ishigami S; Monden K; Ishiguro S; Fujita S; Imamura M
J Surg Res; 1997 Jul; 70(2):124-33. PubMed ID: 9245560
[TBL] [Abstract][Full Text] [Related]
23. Effects and mechanisms of extract from Paeonia lactiflora and Astragalus membranaceus on liver fibrosis induced by carbon tetrachloride in rats.
Sun WY; Wei W; Wu L; Gui SY; Wang H
J Ethnopharmacol; 2007 Jul; 112(3):514-23. PubMed ID: 17574357
[TBL] [Abstract][Full Text] [Related]
24. Astragalus and Paeoniae radix rubra extract inhibits liver fibrosis by modulating the transforming growth factor‑β/Smad pathway in rats.
Huang W; Li L; Tian X; Yan J; Yang X; Wang X; Liao G; Qiu G
Mol Med Rep; 2015 Feb; 11(2):805-14. PubMed ID: 25373883
[TBL] [Abstract][Full Text] [Related]
25. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.
Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M
J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
[TBL] [Abstract][Full Text] [Related]
27. [Effect of gypenosides on DMN-induced liver fibrosis in rats].
Feng Q; Li X; Peng J; Duan X; Fu Q; Hu Y
Zhongguo Zhong Yao Za Zhi; 2012 Feb; 37(4):505-8. PubMed ID: 22667153
[TBL] [Abstract][Full Text] [Related]
28. Effect of pretreatment with artichoke extract on carbon tetrachloride-induced liver injury and oxidative stress.
Mehmetçik G; Ozdemirler G; Koçak-Toker N; Cevikbaş U; Uysal M
Exp Toxicol Pathol; 2008 Sep; 60(6):475-80. PubMed ID: 18583118
[TBL] [Abstract][Full Text] [Related]
29. The protective effects of Hibiscus sabdariffa extract on CCl4-induced liver fibrosis in rats.
Liu JY; Chen CC; Wang WH; Hsu JD; Yang MY; Wang CJ
Food Chem Toxicol; 2006 Mar; 44(3):336-43. PubMed ID: 16176854
[TBL] [Abstract][Full Text] [Related]
30. [Curative effect of interferon-alpha on rat liver fibrosis induced by CCl4].
Yang HX; Yi YR
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):919-25. PubMed ID: 19001734
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of effect of formulas clearing away heat and promoting blood circulation on prevention and treatment of liver fibrosis in CCl4 mice].
Zhao Z; Yu H; Peng Y; Ren H; Tao Y; Wang Z; Zhu B; Liu P; Liu C
Zhongguo Zhong Yao Za Zhi; 2012 Jun; 37(12):1804-8. PubMed ID: 22997828
[TBL] [Abstract][Full Text] [Related]
32. [Inhibitory effect of glycyrrhizin on NF-kappa B binding activity in CCl4 plus ethanol induced liver cirrhosis in rats].
Wang J; Guo J; Liu S
Zhonghua Gan Zang Bing Za Zhi; 1999 Mar; 7(1):42-3. PubMed ID: 10366987
[TBL] [Abstract][Full Text] [Related]
33. [Antioxidant effects of the Uygur herb, Foeniculum Vulgare Mill, in a rat model of hepatic fibrosis].
Zhang ZG; Lu XB; Xiao L; Tang L; Zhang LJ; Zhang T; Zhan XY; Ma XM; Zhang YX
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):221-6. PubMed ID: 22475144
[TBL] [Abstract][Full Text] [Related]
34. [Prevention and treatment of experimental liver fibrosis in rats by Semen Hoveniae extracts].
Geng WX; Ding HY; Yi YS
Zhong Yao Cai; 2008 Oct; 31(10):1550-2. PubMed ID: 19230414
[TBL] [Abstract][Full Text] [Related]
35. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.
Zhang ZQ; Qiu JF; Luo M; Sun YW; Zhao G; Chen W; Liu H; Wu ZY
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013
[TBL] [Abstract][Full Text] [Related]
36. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.
Biecker E; Trebicka J; Kang A; Hennenberg M; Sauerbruch T; Heller J
Liver Int; 2008 Mar; 28(3):331-8. PubMed ID: 18290775
[TBL] [Abstract][Full Text] [Related]
37. Adenosine reverses a preestablished CCl4-induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats.
Hernández-Muñoz R; Díaz-Muñoz M; Suárez-Cuenca JA; Trejo-Solís C; López V; Sánchez-Sevilla L; Yáñez L; De Sánchez VC
Hepatology; 2001 Oct; 34(4 Pt 1):677-87. PubMed ID: 11584363
[TBL] [Abstract][Full Text] [Related]
38. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.
Theodorakis NG; Wang YN; Korshunov VA; Maluccio MA; Skill NJ
World J Gastroenterol; 2015 Apr; 21(14):4126-35. PubMed ID: 25892862
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of leflunomide on hepatic fibrosis induced by CCl4 in rats.
Yao HW; Li J; Chen JQ; Xu SY
Acta Pharmacol Sin; 2004 Jul; 25(7):915-20. PubMed ID: 15210065
[TBL] [Abstract][Full Text] [Related]
40. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
